Bio-Medical Applications Of Minnesota Inc is categorized under Kidney Dialysis Centers in Minneapolis, MN .
Bio-Medical Applications Of Minnesota Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.
If you are seeking more information, feel free to contact Jim Barsanti at the company’s branch by writing to 3465 Northdale Boulevard Nw, Minneapolis, Minnesota MN 55448 or by phoning (763) 862-6088. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bio-Medical Applications Of Minnesota Inc |
| Contact Person: | Jim Barsanti |
| Address: | 3465 Northdale Boulevard Nw, Minneapolis, Minnesota 55448 |
| Phone Number: | (763) 862-6088 |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Kidney Dialysis Centers |
| SIC Code: | 8092 |
| NAICS Code: | 621492 |
| Share This Business: |
Bio-Medical Applications Of Minnesota Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jim Barsanti for inquiries that concern Bio-Medical Applications Of Minnesota Inc by calling the company number (763) 862-6088, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Of Minnesota Inc can be found at the coordinates 45.207396,-93.353253 as well as the street address 3465 Northdale Boulevard Nw in Minneapolis, Minnesota 55448.
For its online presence, you may visit Bio-Medical Applications Of Minnesota Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.